Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q3 2024 Earnings

9AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-0.5

-0.37

-0.23

-0.1

Details

Expected EPS

-0.5

Actual EPS

-0.5

Surprise EPS

0

Surprise Percent

+0%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.5 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.